This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheng, J. Q. Articles by Testa, J. R. Search for Related Content PubMed PubMed Citation Articles by Cheng, J. Q. Articles by Testa, J. R.

Homozygous Deletions within 9p21-p22 Identify a Small Critical Region of Chromosomal Loss in Human Malignant Mesotheliomas¹

Department of Medical Oncology, Fax Chase Cancer Center, Philadelphia, Pennsylvania 19111 [J. Q. C., Y. Y. L., J. R. T.], and Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [S. C. J.]

Previous DNA analyses have demonstrated that 9p13–p22 is a frequent site of chromosomal loss in leukemia, glioma, melanoma, and lung and bladder carcinomas. Recent cytogenetic studies have revealed recurrent alterations of 9p in malignant mesothelioma (MM). We have performed gene dosage studies of 23 MM cell lines, using probes for several 9p21-p22 loci (IFNB, IFNA/IFNW, D9S3, D9S126, D9S169, and D9S171), to identify a common region of deletion. Homozygous and/or hemizygous deletions were identified in 19 (83%) cell lines. Homozygous losses (10 cell lines; 43%) occurred most often at the D9S171 and IFNA/IFNW loci. In 8 cell lines, 2 or more of the 9p loci examined were found to be homozygously lost; 2 others displayed homozygous losses only at the D9S171 locus. Results from our deletion mapping analysis suggest that D9S171 is located between IFNA/IFNW and D9S126. The data presented here indicate that allelic loss from 9p21-p22 is a common occurrence in MM and further delineate the location of a putative 9p tumor suppressor gene(s) to a region between IFNA/IFNW and D9S171. These MM cell lines may facilitate efforts to define an even smaller critically deleted region, leading to the eventual cloning and characterization of this gene.

¹ Supported by National Cancer Institute Grants CA-45745 and CA-06927, and by an appropriation from the Commonwealth of Pennsylvania.

² To whom correspondence should be addressed, at Fox Chase Cancer Center, Department of Medical Oncology, 7701 Burholme Avenue, Philadelphia, Pennsylvania 19111.

Received 7/28/93. Accepted 8/23/93.

This article has been cited by other articles:

				D. A. Altomare, C. A. Vaslet, K. L. Skele, A. De Rienzo, K. Devarajan, S. C. Jhanwar, A. I. McClatchey, A. B. Kane, and J. R. Testa A Mouse Model Recapitulating Molecular Features of Human Mesothelioma Cancer Res., September 15, 2005; 65(18): 8090 - 8095. [Abstract] [Full Text] [PDF]

				P. B. Illei, V. W. Rusch, M. F. Zakowski, and M. Ladanyi Homozygous Deletion of CDKN2A and Codeletion of the Methylthioadenosine Phosphorylase Gene in the Majority of Pleural Mesotheliomas Clin. Cancer Res., June 1, 2003; 9(6): 2108 - 2113. [Abstract] [Full Text] [PDF]

				A Baldi, A M Groeger, V Esposito, R Cassandro, G Tonini, T Battista, M P Di Marino, B Vincenzi, M Santini, A Angelini, et al. Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival Thorax, April 1, 2002; 57(4): 353 - 356. [Abstract] [Full Text] [PDF]

				P. Schraml, K. Struckmann, R. Bednar, W. Fu, T. Gasser, K. Wilber, J. Kononen, G. Sauter, M. J. Mihatsch, and H. Moch CDKN2A Mutation Analysis, Protein Expression, and Deletion Mapping of Chromosome 9p in Conventional Clear-Cell Renal Carcinomas : Evidence for a Second Tumor Suppressor Gene Proximal to CDKN2A Am. J. Pathol., February 1, 2001; 158(2): 593 - 601. [Abstract] [Full Text] [PDF]

				I. Waheed, Z. S. Guo, G. A. Chen, T. S. Weiser, D. M. Nguyen, and D. S. Schrump Antisense to SV40 Early Gene Region Induces Growth Arrest and Apoptosis in T-Antigen-positive Human Pleural Mesothelioma Cells Cancer Res., December 1, 1999; 59(24): 6068 - 6073. [Abstract] [Full Text] [PDF]

				N. Shivapurkar, A. K. Virmani, I. I. Wistuba, S. Milchgrub, B. Mackay, J. D. Minna, and A. F. Gazdar Deletions of Chromosome 4 at Multiple Sites Are Frequent in Malignant Mesothelioma and Small Cell Lung Carcinoma Clin. Cancer Res., January 1, 1999; 5(1): 17 - 23. [Abstract] [Full Text] [PDF]

				A Kamb, N. Gruis, J Weaver-Feldhaus, Q Liu, K Harshman, S. Tavtigian, E Stockert, R. Day 3rd, B. Johnson, and M. Skolnick A cell cycle regulator potentially involved in genesis of many tumor types Science, April 15, 1994; 264(5157): 436 - 440. [Abstract] [PDF]

				A. Kamb Role of a Cell Cycle Regulator in Hereditary and Sporadic Cancer Cold Spring Harb Symp Quant Biol, January 1, 1994; 59(0): 39 - 47. [Abstract] [PDF]